Literature DB >> 19164350

Quality of life measured by the St George's Respiratory Questionnaire and spirometry.

M Weatherall1, S Marsh, P Shirtcliffe, M Williams, J Travers, R Beasley.   

Abstract

The present authors aimed to determine if the criteria for the diagnosis of chronic obstructive pulmonary disease (COPD) and its classification by severity as recommended by the Global Initiative for Chronic Obstructive Lung Disease are supported by measurements of respiratory health-related quality of life. A community-based sample of adults aged 25-75 yrs had pre- and post-bronchodilator spirometry and completed the St George's Respiratory Questionnaire (SGRQ). Loess scatter plot smoothers of the SGRQ versus post-bronchodilator forced expiratory volume in one second (FEV(1))/forced vital capacity (FVC) ratio and post-bronchodilator FEV(1) % predicted together with receiver operating characteristic (ROC) curve analysis were used to determine the relationship between spirometric variables and clinically important differences in the SGRQ score. The scatter plot smoother and ROC curve analyses supported the value of 0.7 for post-bronchodilator FEV(1)/FVC ratio, which was approximately 4 units higher than the nadir of the SGRQ. To represent a distance of 8 units on the SGRQ, the cut-off points for post-bronchodilator FEV(1) that delimit COPD severity stages were 80, 60 and 40% pred for mild, moderate and severe COPD, respectively. To diagnose chronic obstructive pulmonary disease the use of post-bronchodilator forced expiratory volume in one second/forced vital capacity ratio of 0.7 is supported by health-related quality of life measurements. There may be advantages in using forced expiratory volume in one second cut-off points of 80, 60 and 40% predicted for the classification of mild, moderate and severe chronic obstructive pulmonary disease, respectively, similar to the approach recommended for asthma.

Entities:  

Mesh:

Year:  2009        PMID: 19164350     DOI: 10.1183/09031936.00116808

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.

Authors:  Anne Bergeron; Sylvie Chevret; Angela Granata; Patrice Chevallier; Laure Vincent; Anne Huynh; Reza Tabrizi; Hélène Labussiere-Wallet; Marc Bernard; Sylvain Chantepie; Jacques-Olivier Bay; Anne Thiebaut-Bertrand; Sylvain Thepot; Nathalie Contentin; Luc-Matthieu Fornecker; Natacha Maillard; Karine Risso; Ana Berceanu; Didier Blaise; Regis Peffault de La Tour; Jason W Chien; Valérie Coiteux; Gérard Socié
Journal:  JAMA       Date:  2017-08-08       Impact factor: 56.272

2.  Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC).

Authors:  Susana Cedrés; Isela Quispe; Pablo Martínez; Marina Longo; Eva Rodríguez; César Serrano; Eva Muñoz; Esther Pallisa; Enriqueta Felip
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

3.  GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

Authors:  MeiLan K Han; Hana Muellerova; Douglas Curran-Everett; Mark T Dransfield; George R Washko; Elizabeth A Regan; Russell P Bowler; Terri H Beaty; John E Hokanson; David A Lynch; Paul W Jones; Antonio Anzueto; Fernando J Martinez; James D Crapo; Edwin K Silverman; Barry J Make
Journal:  Lancet Respir Med       Date:  2012-09-03       Impact factor: 30.700

Review 4.  Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Authors:  K Suresh Babu; Jack A Kastelik; Jaymin B Morjaria
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

5.  Correlation of cardiopulmonary exercise testing parameters with quality of life in stable COPD patients.

Authors:  Mahsa Mirdamadi; Besharat Rahimi; Enayat Safavi; Hamidreza Abtahi; Soheil Peiman
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

6.  Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.

Authors:  Cristine E Berry; M Bradley Drummond; MeiLan K Han; Daner Li; Cathy Fuller; Andrew H Limper; Fernando J Martinez; Marvin I Schwarz; Frank C Sciurba; Robert A Wise
Journal:  Chest       Date:  2012-09       Impact factor: 9.410

7.  Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study.

Authors:  Mirna Waked; George Khayat; Pascale Salameh
Journal:  Clin Epidemiol       Date:  2011-11-23       Impact factor: 4.790

8.  Cigarette and waterpipe smoking decrease respiratory quality of life in adults: results from a national cross-sectional study.

Authors:  Salamé Joseph; Salameh Pascale; Khayat Georges; Waked Mirna
Journal:  Pulm Med       Date:  2012-09-03

9.  Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.

Authors:  Sunmin Kim; Jisun Oh; Yu-Il Kim; Hee-Jung Ban; Yong-Soo Kwon; In-Jae Oh; Kyu-Sik Kim; Young-Chul Kim; Sung-Chul Lim
Journal:  BMC Pulm Med       Date:  2013-06-03       Impact factor: 3.317

10.  Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease.

Authors:  Meng-Rui Lee; Ching-Yao Yang; Kai-Ping Chang; Li-Ta Keng; David Hung-Tsang Yen; Jann-Yuan Wang; Huey-Dong Wu; Li-Na Lee; Chong-Jen Yu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.